Pablo Zuanic

Cannabis Slowdown In Canada: Analyst Spotlights What Still Sells And Where The Money Is Going
Top Ohio Cannabis Companies: Analyst Look At Stocks With Potential Market Cap Gains
California Cannabis Company Exceeds Sales Expectations, Boosts Production To Improve Margins And Enhance Brands
Top Ohio Cannabis Companies: Analyst Look At Stocks With Potential Market Cap Gains
California Cannabis Company Exceeds Sales Expectations, Boosts Production To Improve Margins And Enhance Brands
Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQ
TILT Holdings' Cannabis Sales Steady Despite Supply Disruptions, Are Debt And Stock Dilution Posing Risks?

Pablo Zuanic Recent News

Florida's Marijuana Market Could Drive 139% Revenue Spike For Planet 13, Fourfold Market Cap Growth
Planet 13 Holdings (OTC: PLNH) has completed its acquisition of VidaCann, reporting $12.5 million in sales for the first quarter of 2024, a 56%
Cannabis Rescheduling: When Will It Happen? Expert Lays Out Timeline, Risks And Wild Cards
The Department of Justice (DOJ) confirmed that it has started the formal rulemaking process to reclassify cannabis to Schedule III. This significant step reinforces the positive outlook for cannabis stocks.
Finally, Tax Refunds! These Cannabis Companies Will Get The Most Money Back If Rescheduling Happens
Significant tax benefits are anticipated for the cannabis industry, following President Joe Biden's confirmation of the administration's intent to reschedule cannabis from Schedule I to Schedule III.
What's Hurting New Jersey Cannabis Sales? Analyst Explains
Pablo Zuanic, a renowned expert in the cannabis market, is a featured speaker at Benzinga's Cannabis Market Spotlight event in New Jersey on June 17, 2024, discussing trends and financial performance. Zuanic's insights will provide valuable context for the state's growing market.
Post Cannabis Rescheduling: What's Next For Marijuana Giants? Potential $1.1B Cash Flow Boost From IRS 280E Removal
Following the recent move on the part of the DEA toward 
Who's Winning In Weed? Analyst Looks At Cannabis Market's Big Players, Where Are The Best Bets?
In the first quarter of 2024, the cannabis sector faces a mixed economic landscape with a notable sequential decline in sales across several states.
No Cannabis Tax Relief In Canada, Tilray CEO Says This 'Hinders Our Ability To Compete With The Illicit Market'
Cannabis Brands Leading Market Expansion In East & Midwest: A Look At Prices And Trends
In a recent sector analysis by Pablo Zuanic of Zuanic & Associates, key trends across four Eastern states are dissected to understand the brand landscape of the cannabis market.
Cannabis Valuations 'More Mathematical, More Balance Sheet Driven' Than Before: Insights From Industry Experts
Experts discussed the evolution of cannabis company valuations, moving from market potential to operational efficiency, profitability, and technology.
Imported Medical Marijuana In Australia Not Tested For Quality, Canada's Cannabis Industry Eager For Tax Cut & More
Analyst Reacts To FDA Commish Comments: Medical And Recreational Cannabis Could Have Separate Regulations
FDA Commissioner Robert Califf's Thursday testimony sparked new conversations about the future of cannabis in the U.S. particularly concerning its medical and recreational classifications.
Mortgage And Property Finance Giant's $354M Portfolio: Growth Amid Cannabis Sector Volatility
In a recent equity research report by Zuanic & Associates, Chicago Atlantic Real Estate Finance (NASDAQ: REFI) showcases resilience and growth within the volatile cannabis sector.
NASDAQ-Listed Marijuana Stocks, Tilray, Canopy, Aurora Rally: What's Behind The Surge?
The Canadian cannabis sector is witnessing a notable upswing, driven by recent developments including Tilray's (NASDAQ: TLRY) earnings report, Organigram's investor day (NASDAQ: OGI) and pivotal movements by Canopy Growth (NASDAQ:
How To Secure Dividends And Returns In Marijuana Real Estate: Analysis Reveals Stock With Potential
New Lake Capital Partners (OTC: NLCP) has emerged as a key player, capitalizing on the industry's expansion and the increasing need for capital among multi-state operators (MSOs).
Florida's $6B Cannabis Market Anticipates 400% Growth Following Court Decision Allowing Nov. Legalization Ballot
Following the pivotal decision by the Florida Supreme Court, senior analyst Pablo Zuanic of Zuanic & Associates released a comprehensive report outlining the potent
California's Weed Sales Decline: Market Ripe For Consolidation, Biggest Companies Likely To Benefit
The California cannabis sector is facing a sales decline, according to a recent market update from Pablo Zuanic, senior equity research analyst at Zuanic & Associates.
Canadian Cannabis Companies Could See Valuations Soar By Up To 300% With Tax Reform, New Report Shows
According to a recent official report, the Canadian government is considering revising the excise tax framework established in 2018 for the cannabis industry.
VP Harris, DEA, FDA Eye Cannabis: Key Changes Ahead, Here's What One Expert Predicts
Vice President Harris's urgent call to the DEA to expedite the rescheduling of cannabis marks a crucial turning point in national drug policy, as analyzed in a comprehensive equity research report by Zuanic & Associates.
Jushi Beats All Expectations: Cannabis Company Surpasses Analysts' 4Q23 Sales And Profit Forecasts
The multi-state cannabis company Jushi Holdings (OTC: JUSHF), reported a significant increase in unique patient visits in Virginia, indicating robust growth in the fourth quarter of 2023.
NASDAQ-Listed Village Farms Grabs #2 Spot In Canada's Cannabis Market: What's Its Winning Formula?
Cannabis company Village Farms International, Inc. (NASDAQ: VFF) is making noteworthy strides, securing the #2 position in the recreational cannabis market in Canada.
Green Thumb's Edge Over S&P 500 & ETFs: Cannabis Investor Confidence Propels Expansion Into Key States
Green Thumb Industries Inc. (OTC: GTBIF) is ramping up investments across Minnesota, Ohio, Virginia, Florida and Pennsylvania to gear up for recreational marijuana legalization.
Marijuana Company Verano Holdings Worth $2.1B, Outprices Its Expected 2024 Earnings
Despite facing retail pressures, especially in New Jersey, which is leading to an expected 5-7% dip in Q1 2024 sales, Verano Holdings (OTC: VRNOF) is still poised for growth, says senior analyst Pablo Zuanic.
MariMed Wholesale Revenue Up 48% Driven By Top Marijuana Brands: Why Is This Weed Stock Undervalued?
MariMed Inc. (OTC: MRMD), a notable player in the US cannabis market, recently reported its financial results and forward-looking guidance, revealing strategic moves to navigate the sector's evolving landscape.